Kirby John J.
Interim CFO
Kirby John J. has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Kirby John J. is listed as Interim CFO at Verrica Pharmaceuticals Inc. Inside the rolling window, Kirby John J. reported 2 open-market purchases totaling $40K in VRCA and no open-market sales. The largest disclosed transaction in the window is a purchase of 5,000 VRCA shares on Aug 18, 2026, worth $25K.
Companies traded
Other insiders at VRCA
Insider Buying
$40K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kirby John J. made?
Kirby John J. has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Kirby John J. trade?
Kirby John J. has filed SEC Form 4 disclosures for 1 company, including VRCA.
When was Kirby John J.'s most recent SEC Form 4 filing?
Kirby John J.'s most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Kirby John J.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kirby John J. is listed as Interim CFO.
What is Kirby John J.'s total buy and sell value in the current window?
Inside the rolling retention window, Kirby John J. bought $40K and sold $0 based on SEC Form 4 filings.
What was Kirby John J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,000 VRCA shares on 2026-08-18, worth $25K, per SEC Form 4 filings.